No Data
No Data
No Data
No Data
No Data
華潤醫藥:公告有關於中國發行中期票據及公司債券的華潤醫藥控股截至2024年3月31日止三個月的未經審核財務業績
Futu NewsApr 30 22:14 · Announcements
China Resources Pharmaceutical (03320.HK): Jiangzhong Pharmaceutical's net profit of 267 million yuan in the first quarter increased 9.99% year-on-year
Gelonghui, April 29丨China Resources Pharmaceutical (03320.HK) announced that Jiangzhong Pharmaceutical (600750.SH) achieved operating income of 1,227 billion yuan in the first quarter of 2024, down 8.74% year on year; net profit attributable to shareholders of listed companies (Jiangzhong Pharmaceutical) was 267 million yuan, up 9.99% year on year; net profit attributable to shareholders of listed companies (Jiangzhong Pharmaceutical) after deducting non-recurring profit and loss was 264 million yuan, up 16.64% year on year.
Gelonghui FinanceApr 29 08:11
華潤醫藥:公告江中藥業截至2024年3月31日止三個月的未經審核財務業績
Futu NewsApr 29 08:01 · Announcements
Express News | China Stem Cell Group signs contract with China Resources Pharmaceutical Commercial Group to complement each other's strengths and promote transformation of results
BreakingsApr 28 13:13
China Resources Pharmaceutical (03320.HK): Donga Ejiao's net profit of 353 million yuan in the first quarter increased 53.43% year-on-year
Gelonghui, April 26 | China Resources Pharmaceutical (03320.HK) announced that Donga Ejiao (000423.SZ)'s revenue for the first quarter of 2024 was 1,453 billion yuan, up 35.95% year on year; net profit attributable to shareholders of listed companies (Donga Ejiao) was 353 million yuan, up 53.43% year on year; net profit attributable to shareholders of listed companies (Donga Ejiao) after deducting non-recurring profit and loss was 329 million yuan, up 54.79% year on year; basic earnings per share were 0.5488 yuan.
Gelonghui FinanceApr 26 07:10
華潤醫藥:公告東阿阿膠截至2024年3月31日止三個月的未經審核財務業績
Futu NewsApr 26 06:52 · Announcements
No Data
No Data